tranexamic acid baxter süste-/infusioonilahus
baxter holding b.v. - traneksaamhape - süste-/infusioonilahus - 100mg 1ml 10ml 10tk; 100mg 1ml 5ml 10tk; 100mg 1ml 5ml 5tk; 100mg 1ml 10ml 5tk
tranexamic acid kabi infusioonilahus
fresenius kabi polska sp. z o.o. - traneksaamhape - infusioonilahus - 10mg 1ml 50ml 50tk; 10mg 1ml 50ml 40tk; 10mg 1ml 100ml 50tk; 10mg 1ml 50ml 10tk; 10mg 1ml 100ml 10tk; 10mg 1ml 100ml 20tk; 10mg 1ml 100ml 40tk
klacid 125mg/5ml suukaudse suspensiooni graanulid
abbvie s.r.l. - klaritromütsiin - suukaudse suspensiooni graanulid - 25mg 1ml 60ml 1tk; 25mg 1ml 100ml 1tk
xenpozyme
sanofi b.v. - olipudase alfa - acid sphingomyelinase deficiency (asmd) type a/b or type b - muud alimentary seedetrakti ja ainevahetust tooted, - xenpozyme is indicated as an enzyme replacement therapy for the treatment of non-central nervous system (cns) manifestations of acid sphingomyelinase deficiency (asmd) in paediatric and adult patients with type a/b or type b.
nobivac ducat süstesuspensiooni lüofilisaat ja lahusti
intervet international b.v. - kasside rinotrahheiidi viirusvaktsiin+kasside kalitsiviirusvaktsiin - süstesuspensiooni lüofilisaat ja lahusti - 4,8log10 tcid50+4,6log10 pfu 1annus 5annus; 4,8log10 tcid50+4,6log10 pfu 1annus 10annus; 4,8log10 tcid50+4,6log10 pfu 1annus 25annus
nobivac dp plus
intervet international b.v. - live attenuated canine distemper virus strain onderstepoort: 105.1 – 106.5 tcid50, live recombinant canine parvovirus strain 630a: 105.1 – 106.7 tcid50 - immuunväetised koertel - dogs (small) - for the active immunisation of puppies from 4 weeks of age onwards to prevent clinical signs and mortality of canine distemper virus infection and canine parvovirus infection and to prevent viral excretion following canine distemper virus infection and following canine parvovirus infection.